High expression of HAVCR1 correlated with a worse prognosis in Liver hepatocellular carcinoma (HR = 1.74, 95% CI: 1.14–2.67, and p = 0.0093, Figure 3A) and Pancreatic adenocarcinoma (HR = 2.01, 95% CI: 1.31–3.07, and p = 0.0011, Figure 3B). The gene discussed is HAVCR1; the disease is pancreatic adenocarcinoma.